ArticlePharmaceuticals (Basel, Switzerland)2023

Therapeutic Outcomes of High Dose-Dexamethasone versus Prednisolone + Azathioprine, Rituximab, Eltrombopag, and Romiplostim Strategies in Persistent, Chronic, Refractory, and Relapsed Immune Thrombocytopenia Patients.

Eman Mostafa Hamed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.